NCT06964308 Thoracoscopic Pleural Biopsy in Sohag University Hospital
| NCT ID | NCT06964308 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Pleural Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-10-01 with a primary completion date of 2025-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.
Eligibility Criteria
Inclusion Criteria: * Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy * Age: Adults aged 18 years and older * Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy. Exclusion Criteria: * Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy * Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy). * Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation. * Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations. * Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons. * Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06964308 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pleural Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06964308 currently recruiting?
Yes, NCT06964308 is actively recruiting participants. Contact the research team at ahmedosamayehya37@yahoo.com for enrollment information.
Where is the NCT06964308 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06964308 clinical trial?
NCT06964308 is sponsored by Sohag University. The trial plans to enroll 36 participants.